Literature DB >> 16339843

Molecular characterization of methicillin-resistant Staphylococcus aureus bloodstream isolates from Croatia.

Ana Budimir1, Ruud H Deurenberg, Vanda Plecko, Cornelis Vink, Smilja Kalenic, Ellen E Stobberingh.   

Abstract

OBJECTIVES: The objectives of this study were (i) to investigate the genetic background of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Croatia and (ii) to monitor the prevalence of Panton-Valentine leucocidin (PVL) and toxic shock syndrome toxin-1 (TSST-1) among these isolates.
METHODS: Eighty-two hospital-acquired MRSA bloodstream isolates, collected in 2001 and 2002 in Croatia, were characterized by PFGE, staphylococcal cassette chromosome mec (SCCmec) typing and multilocus sequence typing (MLST). The presence of genes encoding PVL and TSST-1 was investigated by real-time PCR.
RESULTS: All strains were multiresistant and were distributed among 16 different similarity groups as determined by PFGE. Two of the groups, groups H and K, harboured the majority of the MRSA strains with 52 and 12%, respectively. The predominant SCCmec type found among the isolates was type I (89%). Eleven per cent of the strains harboured a modified SCCmec type III, which contained, in contrast to the regular type III, an additional dcs region. One strain harboured a novel SCCmec type, containing the ccrC gene in combination with the mecI gene, the dcs region, the locus between pI258 and Tn554 (locus E) and the locus between Tn554 and orfX (locus F). MLST showed the presence of ST111-MRSA-I and ST247-MRSA-I among Croatian MRSA isolates. All isolates were negative for both PVL and TSST-1.
CONCLUSIONS: These results indicate the emergence of ST111-MRSA-I and ST247-MRSA-I in Croatia among MRSA bloodstream isolates. The virulence factors PVL and TSST-1 were not present among these isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339843     DOI: 10.1093/jac/dki452

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Genetic diversity of methicillin-resistant Staphylococcus aureus in a tertiary hospital in The Netherlands between 2002 and 2006.

Authors:  E Nulens; E E Stobberingh; E Smeets; H van Dessel; M A Welling; S Sebastian; F H van Tiel; P S Beisser; R H Deurenberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-08       Impact factor: 3.267

2.  MRSA SCCmec epidemiology in Israel: development and implementation of an MRSA SCCmec typing strategy.

Authors:  D Alon; F Abd-Elkadir; M Chowers; Y Paitan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-10       Impact factor: 3.267

3.  Genetic background and antibiotic resistance of Staphylococcus aureus strains isolated in the Republic of Georgia.

Authors:  Tamara Revazishvili; Lela Bakanidze; Tsaro Gomelauri; Ekaterine Zhgenti; Gvantsa Chanturia; Merab Kekelidze; Chythanya Rajanna; Arnold Kreger; Alexander Sulakvelidze
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  Typing of staphylococcal cassette chromosome mec encoding methicillin resistance in Staphylococcus aureus strains isolated at the bone marrow transplant centre of Tunisia.

Authors:  O Bouchami; W Achour; Assia Ben Hassen
Journal:  Curr Microbiol       Date:  2009-07-09       Impact factor: 2.188

5.  Cotton textiles modified with citric acid as efficient anti-bacterial agent for prevention of nosocomial infections.

Authors:  Sandra Bischof Vukušić; Sandra Flinčec Grgac; Ana Budimir; Smilja Kalenić
Journal:  Croat Med J       Date:  2011-02       Impact factor: 1.351

6.  Typing of Methicillin Resistant Staphylococcus Aureus Using DNA Fingerprints by Pulsed-field Gel Electrophoresis.

Authors:  Velma Rebic; Ana Budimir; Mufida Aljicevic; Sabaheta Bektas; Sabina Mahmutovic Vranic; Damir Rebic
Journal:  Acta Inform Med       Date:  2016-07-16

7.  Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from tertiary care hospitals.

Authors:  Atif H Asghar
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.